rs773071023
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The ENST00000304874.14(ASL):c.1300G>T(p.Val434Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V434V) has been classified as Likely benign.
Frequency
Consequence
ENST00000304874.14 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASL | NM_000048.4 | c.1300G>T | p.Val434Leu | missense_variant | 17/17 | ENST00000304874.14 | NP_000039.2 | |
ASL | NM_001024943.2 | c.1300G>T | p.Val434Leu | missense_variant | 16/16 | NP_001020114.1 | ||
ASL | NM_001024944.2 | c.1240G>T | p.Val414Leu | missense_variant | 15/15 | NP_001020115.1 | ||
ASL | NM_001024946.2 | c.1222G>T | p.Val408Leu | missense_variant | 15/15 | NP_001020117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASL | ENST00000304874.14 | c.1300G>T | p.Val434Leu | missense_variant | 17/17 | 1 | NM_000048.4 | ENSP00000307188 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250932Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135738
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461522Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727088
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Argininosuccinate lyase deficiency Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 06, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Apr 20, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 434 of the ASL protein (p.Val434Leu). This variant is present in population databases (rs773071023, gnomAD 0.003%). This missense change has been observed in individual(s) with argininosuccinic aciduria (PMID: 24166829, 30285816). ClinVar contains an entry for this variant (Variation ID: 557968). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASL protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2022 | The c.1300G>T (p.V434L) alteration is located in exon 17 (coding exon 16) of the ASL gene. This alteration results from a G to T substitution at nucleotide position 1300, causing the valine (V) at amino acid position 434 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at